CODX Co-Diagnostics Inc: Accounting Value per Share

The potential of Co-Diagnostics, Inc. (CODX) is based on the automation of PCR assays, which eliminates manual labor. The book value per common share clearly demonstrates asset dynamics, with the value stabilizing at 2.60. However, sales are constrained by US and Chinese trade barriers, while falling demand for tests forces the company to compete aggressively for market share against major players.

Co-Diagnostics Inc (CODX) - Accounting Value per Share from 07/04/2022 to 10/27/2026

Summary analytical data breakdowns for codiagnostics.com (CODX)

- price and consensus price forecast:

Stock Price Co-Diagnostics Corp|CODX - Broker Consensus Forecast

- market capitalization data:

Market Valuation Co-Diagnostics, Inc.|CODX - Business Value

- book capitalization data:

Net Assets per Single Share Co-Diagnostics|CODX - Company Net Assets|Market Capitalization to Book Value Ratio codiagnostics.com|CODX - Company Assets

- debt and liquidity data:

Total Debt to Capital Co-Diagnostics, Inc.|CODX - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Co-Diagnostics|CODX - Company Aggregate Debts|Debt to Book Capitalization Ratio Co-Diagnostics, Inc.

Fundamental company valuation:Co-Diagnostics, Inc.

Manufactured product of codiagnostics.com

To objectively assess the stability of Co-Diagnostics, Inc. (CODX), it is critical for a portfolio manager to calculate the net asset value per share, which measures the real value of the business's tangible assets and reserves. By analyzing the trend of the book value per share, an investor can track the accumulation of resources, which in this case is supported by the localization of production in the US and the optimization of reagent logistics to minimize external shocks.

Competitors of Co-Diagnostics, Inc. (CODX)